Products & ReviewLife Sciences

iLite® CD3 effector cell/ T-Cell activation Bioassays

Svar Life Science ABAvailable: Worldwide

The iLite® CD3 Effector Cell line is a reporter gene cell line that offers a convenient and powerful way of measuring the efficacy antibodies have to elicit  T cell activation through CD3  interactions.

Request Pricing
Svar Life Science AB

Receive your quote directly from the manufacturer.

Ease of Use
After Sales Service
Value for Money
Write your own review

In recent years, a variety of immunotherapy strategies aimed at inducing, strengthening, and/or engineering T cell responses have emerged as promising approaches for the treatment of diseases such as cancer and autoimmunity. With the iLite CD3 Effector cell - a cleverly engineered effector cell that closely resembles the natural engagement of the TCR/CD3 complex, and homologous target cells with a controlled antigen expression (+) or depletion (-), this can be assessed with a robust assay. The iLite T-Cell Activation Bioassays is a dual cell system based on bioluminescent cell-based assays. The portfolio consists of cell lines provided in an “assay-ready” format for a rapid and convenient workflow and a further reduction in assay variability and can be used for the discovery and development of novel biologics such as bispecific antibodies and CAR-T cell therapies.

Product Overview

Links